Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Hex3Cer 34:1;O2)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004217 AN007016 Lipid Alterations in ASAH1-Deficient Cells: Insights into Ceramide Accumulation and Lysosomal Dysfunction Cultured cells Human Metabolic disease Harvard Medical School LC-MS
ST004167 AN006918 Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells Renal cancer cells Human Cancer The Affiliated Cancer Hospital of Zhengzhou University LC-MS
ST003678 AN006039 The effects of cystine limitation stress adaptation (CLSA) on lipidomics changes in pancreatic cancer cells Pancreas Human Cancer Pennsylvania State University LC-MS
ST003632 AN005965 Dysregulated Lipid Metabolism in African American Women Who Experienced Cardiometabolic Complications of Pregnancy Blood Human Preeclampsia Emory University LC-MS
ST003051 AN005002 Shotgun lipidomics of breast cancer endocrine therapy persisters Breast cancer cells Human Cancer Dartmouth College LC-MS
ST002967 AN004875 Lipidomics study of FASN inhibition in HT-29 and HCT 116 spheroids Cultured cells Human Cancer Ohio State University LC-MS
ST002713 AN004397 Ranolazine induced metabolic rewiring improves melanoma responses to targeted therapy and immunotherapy - lipidomics Cultured cells Human Cancer University of Colorado Denver LC-MS
ST002522 AN004156 Lipidomics study on the effect of LBP protein on hepatic lipid composition in mice Liver Mouse Oxidative stress University of Science and Technology of China LC-MS
ST002505 AN004127 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China LC-MS
  logo